CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Procalcitonin as a predictive value for intestinal ischemia and necrosis in acute intestinal obstruction patients underwent urgent operation

Author: 
Abd-El-Aal A. Saleem and Emad F. Kholef
Subject Area: 
Health Sciences
Abstract: 

OBJECTIVE: To assess the value of procalcitonin for early detection of intestinal ischemia and necrosis in patients suffering from acute intestinal obstruction on presentation at emergency department before urgent operation. METHODS PATIENTS AND: This was a prospective study of 80 patients who suffering from acute intestinal obstruction and underwent urgent operation in emergency department of Aswan University Hospital. This 80 patients were divided into two groups. Group A (non-ischemia group, n=28). Group B (ischemia group, n=52), this group was divided into two subgroups (B1and B2). B1 (32 patients) was considered as reversible ischemia group and B2 (20 patients) was considered as irreversible ischemia group. Group A and subgroup B1 (60 patients) was considered as non-necrosis group but subgroup B2 (20 patients) was considered as necrosis group. Group C (20 patients) was considered as control group. The important analyzed data included age, sex, special habits, the time between symptom onset and arrival at the emergency department, vital signs, symptoms, clinical findings, white blood cells count, base deficit, metabolic acidosis, serum procalcitonin levels on presentation at emergency department, the time between arrival and operation, operative findings and what’s done, post-operative complications and outcome. RESULTS: Serum Procalcitonin level shows insignificant deference between control and non-ischemia groups 0.33 vs 0.47 ng/ml (P= 0.15). But there was significant increase in the serum procalcitonin levels in ischemia than non-ischemia groups 4.40 vs 0.47 ng/ml (P = <0.0001) and in necrosis than non-necrosis groups 9.46 vs 0.88 ng/ml (P = <0.0001). Multivariate analysis identified serum procalcitonin as an independent predictor of intestinal ischemia in acute intestinal obstruction (P = 0.001, odds ratio 7.17, 95%. confidence interval 2.31-22.21) and necrosis (P = 0.002, odds ratio 1.71, confidence interval 1.21- 2.42). Using receiver operating characteristic (ROC) curve analysis, the area under the curve (AUC) of serum procalcitonin for intestinal ischemia and necrosis was 0.85 and 0.81 respectively. A high negative predictive value (NPV) for intestinal ischemia and necrosis of serum procalcitonin levels at <0.36 ng/ml (cut off point) was 80% and 90% respectively. Also a positive predictive value (PPV) for intestinal ischemia and necrosis of serum procalcitonin at >1.77ng/ml were 92% and 70% respectively. CONCLUSION: Serum procalcitonin levels on presentation at emergency department were an independent predictor of intestinal ischemia and necrosis. Thus procalcitonin may be useful for early detection or exclusion of intestinal ischemia and necrosis in acute intestinal obstruction and can be used as an additional diagnostic tool to improve clinical decision-making.

PDF file: 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran